Advertisement
ATC features three State-of-the-Art addresses by leading scientists, new audience response sessions and hundreds of presentations covering crucial data in transplantation science and medicine. Controversial topics and important new data will be offered daily. "This 10th anniversary ATC will be an unprecedented meeting in terms of quality and content," said John Iacomini, PhD, a chair of ATC.
Advertisement
State-of-the-Art Addresses are:
A focus on "Hot" topics will spotlight the conference. A fun, interactive session on May 3(rd) "Transplant Jeopardy: Essential Infectious Disease", created to mimic the television game show has top doctors (Jeffrey Crippin MD, Richard Freeman MD, and Barbara Murphy MD) solving clinical challenges. Afterwards, they will present lectures on infectious disease topics.
Additional notable presentations throughout the meeting include "Towards Tolerance in Transplantation: Who are the New Players", "Can a Regulated System for Living Donor Incentives Work?" and "Calcineurin Inhibitors: Love 'em or Leave 'em".
ATC Highlights:
Infectious Diseases
"What's Hot, What's New"?
Stem & Islet Cells
FDA Drug Developments
Ethics, Economics & Regulatory Issues
Clinical Trials
NanoMedicine
Donation After Cardiac Death
Expanded Criteria Donors
National Kidney Paired Donations
Tissue Engineering
Organ Allocation Worldwide
Transplantation Controversies
Biologic Immunosuppression Agents
Cancer Pathogenesis
Cardiac Risks
For more information about the American Society of Transplant Surgeons, visit www.asts.org. Learn more about the American Society of Transplantation at www.a-s-t.org. Visit www.atcmeeting.org/2010 for meeting schedule, key speakers, and more. Media interviews are encouraged.
-- Michael J. Bevan, PhD, FRS, Howard Hughes Medical Institute and University of Washington, presenting "Regulation of the CD8 T Cell Response" on Sunday, May 2(nd). -- Shimon Sakaguchi, MD, PhD, Institute for Frontier Medical Sciences at Kyoto University, speaking May 3(rd) on "Regulatory T Cells for Immunological Tolerance". -- Richard A. Flavell, PhD, FRS, Sterling Professor of Immunobiology at Yale University School of Medicine, and a Howard Hughes Medical Institute Investigator addressing the latest developments in "Innate and Adaptive Immunity" on May 5(th).
SOURCE American Transplant Congress 2010